News Mylan recalls pricey US EpiPens, but cheaper version unaffec... More trouble for embattled Mylan.
News Charities unite to oppose NICE rare disease rules MPs to discuss controversial plan in special debate.
News Will the NHS force doctors to prescribe biosimilars? NHS authorities could begin to use the reimbursement system as a “stick” to ensure doctors prescribe cheaper biosimilar medicines amid varied uptake in different regions.
News Drug price crackdown imminent, says Trump President Donald Trump has issued a fresh threat against pharma, saying a drug price crackdown could be worked in to new healthcare reforms.
News Drug price controversies hit pharma's reputation Patient groups slam pharma over drug costs in latest survey.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
